Oxazatricyclic noradamantanes: Stereocontrolled synthesis of functionalized scopolines, related cage molecules, and drug leads

Organic Letters

Volumn 6, Issue 23, 2004, Pages 4155-4158

  Pascual, María Vidal ^a   Proemmel, Steffen ^a   Beil, Winfried ^b   Wartchow, Rudolf ^a   Hoffmann, H M R ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b Medical University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SCOPOLAMINE DERIVATIVE;

ARTICLE; CYCLIZATION; DRUG SYNTHESIS; EPOXIDATION; MOLECULAR DYNAMICS; STEREOCHEMISTRY;

EID: 9444297826     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol048603t     Document Type: Article

References (31)

1. Derwick, P. M. Medicinal Natural Products; Wiley: Chichester, UK, 1998; Chapter 6.
2. Reviews: (a) Singh, S. Chem. Rev. 2000, 100, 925. (b) Fodor, G. In Rodd's Chemistry of Carbon Compounds, 2nd ed.; Sainsbury, M., Ed.; Elsevier: Amsterdam, 1997; Vol. 4, pp 4251-4276.
3. Reviews: (a) Singh, S. Chem. Rev. 2000, 100, 925. (b) Fodor, G. In Rodd's Chemistry of Carbon Compounds, 2nd ed.; Sainsbury, M., Ed.; Elsevier: Amsterdam, 1997; Vol. 4, pp 4251-4276.
4. (a) Heusner, A. Chem. Ber. 1954, 87, 1063.
5. (b) Fodor, G.; Kovacs, O. J. Chem. Soc. 1953, 2341.
6. (c) Stereochemistry and configuration of scopolamine: Fodor, G. Tetrahedron 1957, 1, 86.
7. Waters, J. A.; Creveling, C. R.; Witkop, B. J. Med. Chem. 1974, 17, 488.
8. Zeile, K.; Heusner, A. Chem. Ber. 1957, 90, 2800-2809.
9. Zaugg, H. E. U.S. Patent 2,927,925, 1960; Chem. Abstr. 1960, 54, 14293.
10. Enzymatic resolution of (±)-scopoline: Cramer, N.; Laschat, S.; Baro, A. Synlett 2003, 2178.
11. (a) Fierz, G.; Chidgey, R.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. Engl. 1974, 13, 410.
12. (b) Hayakawa, Y.; Baba, Y.; Makino, S.; Noyori, R. J. Am. Chem. Soc. 1978, 100, 1786.
13. (c) Mann, J.; Barbosa, L.-C. J. Chem. Soc., Perkin Trans. 1 1992, 787. See, however: Hodgson, D. M.; Paruch, E. Tetrahedron 2004, 60, 5185. The classical Robinson tropinone synthesis proceeds with umpolung of reactivity from three-carbon and four-carbon building blocks. See: Robinson, R. J. Chem. Soc. 1917, 762.
14. (c) Mann, J.; Barbosa, L.-C. J. Chem. Soc., Perkin Trans. 1 1992, 787. See, however: Hodgson, D. M.; Paruch, E. Tetrahedron 2004, 60, 5185. The classical Robinson tropinone synthesis proceeds with umpolung of reactivity from three-carbon and four-carbon building blocks. See: Robinson, R. J. Chem. Soc. 1917, 762.
15. (c) Mann, J.; Barbosa, L.-C. J. Chem. Soc., Perkin Trans. 1 1992, 787. See, however: Hodgson, D. M.; Paruch, E. Tetrahedron 2004, 60, 5185. The classical Robinson tropinone synthesis proceeds with umpolung of reactivity from three-carbon and four-carbon building blocks. See: Robinson, R. J. Chem. Soc. 1917, 762.
16. Hartung, I. V.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 2004, 43, 1934.
17. Compare also synthesis of epibatidine: Fletcher, S. R.; Baker, R.; Chambers, M. S.; Herbert, R. R.; Hobbs, S. C.; Thomas, S. R.; Verrier, H. M.; Watt, A. P.; Ball, R. G. J. Org. Chem. 1994, 59, 1771.
18. Experimental procedure submitted to Org. Synth., available on e-mail request from the corresponding author.
19. (a) Baxter, E. W.; Reitz, A. B. Org. React. 2002, 59, 1.
20. (b) Abdel-Magid, A. F.; Garson, K. G.; Harris, B. D.; Maryanoff, C. A., Shaw, R. D. J. Org. Chem. 1996, 61, 3849.
21. (a) Reinecke, J.; Hoffmann, H. M. R. Chem. Eur. J. 1995, 1, 368.
22. (b) Wittenberg, J.; Beil, W.; Hoffmann, H. M. R. Tetrahedron Lett. 1998, 39, 8259.
23. (c) Proemmel, S.; Hoffmann, H. M. R.; Beil, W. Tetrahedron 2002, 58, 6199.
24. GI50 = concentration causing 50% growth inhibition; TGI = concentration causing 100% growth inhibition; LC50 = concentration causing 50% reduction of the cells present.
25. New Chemical Entity; see: Rouhi, A. M. Chem. Eng. News 2003, Oct 13, 77, 93, 104.
26. Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 1998, 37, 1266. Pierau, S.; Hoffmann, H. M. R. Synlett 1999, 213. Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684. Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883.
27. Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 1998, 37, 1266. Pierau, S.; Hoffmann, H. M. R. Synlett 1999, 213. Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684. Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883.
28. Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 1998, 37, 1266. Pierau, S.; Hoffmann, H. M. R. Synlett 1999, 213. Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684. Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883.
29. Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 1998, 37, 1266. Pierau, S.; Hoffmann, H. M. R. Synlett 1999, 213. Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684. Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883.
30. Lipinski, C. A. Drug Discovery Today 2003, 8, 12.
31. CCDC 240296 (10a), CCDC 240294 (11b), CCDC 240297 (11-OH), and CCDC 240295 (13a) can be obtained from the Cambridge Crystallographic Data Centre, deposit@ccdc.cam.ac.uk.